Novartis vows to fight U.S. price-fixing claims against Sandoz unit
Novartis on Monday said claims of price fixing against its Sandoz generics unit amid a U.S. probe of 20 drugmakers are without merit, with the Swiss company vowing to fight allegations in a lawsuit filed last week. Reuters Health News
In Charge of Animal Disease Study, and Surveillance Bureau, expert on Disease Study, Surveillance, Early Warning/Response, Client Training, and Development. Executive Officer for projects avoiding spread of diseases. Works at Iran Veterinary Organization; Veterinarian, 2000 - present.